Arvind Rajwanshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arvind Rajwanshi has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
- Nalini Gupta
Department of Cytology and Gynecological Pathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
24 shared publications - Pranab Dey
Department of Cytology Post Graduate Institute of Medical Education and Research Chandigarh India
15 shared publications - Radhika Srinivasan
Department of Cytology and Gynecological Pathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
15 shared publications - Parikshaa Gupta
Department of Cytology and Gynecological Pathology Postgraduate Institute of Medical Education and Research Chandigarh India
14 shared publications - Manish Rohilla
Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
9 shared publications - Gargi Kapatia
Department of Pathology, All India Institute of Medical Sciences (AIIMS), Bathinda, India
5 shared publications
Latest Publications
- 22 December 2025
- Published by S. Karger AG in Acta Cytologica
- p. 1-20
Cytopathologic Diagnosis of Non-Neoplastic Inflammatory Disorders of Lymphoid Organs
Background: Fine-needle aspiration biopsy (FNAB) is a minimally invasive, cost-effective, and accurate method for evaluating enlarged lymph nodes, especially useful in pediatric cases where most aspirates are benign. It can be performed by palpation or under ultrasound guidance for deeper lesions. Rapid onsite evaluation enhances specimen adequacy and guides ancillary testing. FNAB, often combined with flow cytometry, can reduce the need for surgical biopsies by up to 86%, with reported sensitivity and specificity of 85–95% and 98–100%, respectively. Summary: Despite its advantages, FNAB is sometimes undervalued due to misconceptions about its diagnostic capabilities. The recently introduced WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology, based on the Sydney System, aims to standardize reporting. It categorizes aspirates into five diagnostic groups, each with an associated risk of malignancy (ROM) and management recommendations. The “benign” category is the most common and includes non-neoplastic inflammatory conditions. Cytopathologists assess cellularity and cytologic features to distinguish benign from atypical or malignant processes. Low-power evaluation of smear patterns helps differentiate infectious from reactive causes. Flow cytometry is crucial for identifying lymphoproliferative disorders and leukemic infiltrates. The ROM for benign FNABs ranges from 2 to 16%, with a pooled estimate of 5%. Management typically involves clinical follow-up, with repeat FNAB or biopsy reserved for persistent or suspicious cases. Familiarity with lymph node cytology and integrated diagnostic approaches is essential for accurate patient care. Key Messages: Familiarity with lymph node cytology and integrated diagnostic approaches is essential for accurate patient care.
- 22 December 2025
- Published by S. Karger AG in Acta Cytologica
- p. 1-20
Cytopathologic Diagnosis of Non-Neoplastic Inflammatory Disorders of Lymphoid Organs
Background: Fine-needle aspiration biopsy (FNAB) is a minimally invasive, cost-effective, and accurate method for evaluating enlarged lymph nodes, especially useful in pediatric cases where most aspirates are benign. It can be performed by palpation or under ultrasound guidance for deeper lesions. Rapid onsite evaluation enhances specimen adequacy and guides ancillary testing. FNAB, often combined with flow cytometry, can reduce the need for surgical biopsies by up to 86%, with reported sensitivity and specificity of 85–95% and 98–100%, respectively. Summary: Despite its advantages, FNAB is sometimes undervalued due to misconceptions about its diagnostic capabilities. The recently introduced WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology, based on the Sydney System, aims to standardize reporting. It categorizes aspirates into five diagnostic groups, each with an associated risk of malignancy (ROM) and management recommendations. The “benign” category is the most common and includes non-neoplastic inflammatory conditions. Cytopathologists assess cellularity and cytologic features to distinguish benign from atypical or malignant processes. Low-power evaluation of smear patterns helps differentiate infectious from reactive causes. Flow cytometry is crucial for identifying lymphoproliferative disorders and leukemic infiltrates. The ROM for benign FNABs ranges from 2 to 16%, with a pooled estimate of 5%. Management typically involves clinical follow-up, with repeat FNAB or biopsy reserved for persistent or suspicious cases. Familiarity with lymph node cytology and integrated diagnostic approaches is essential for accurate patient care. Key Messages: Familiarity with lymph node cytology and integrated diagnostic approaches is essential for accurate patient care.
- 14 October 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (2) , 201-210
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus
Background: The International Academy of Cytology in collaboration with the International Agency for Research on Cancer has developed a standardized World Health Organization Reporting System (WHO System) for the cytopathology of the lymph nodes, spleen, and thymus. Fine-needle aspiration biopsy (FNAB) of the spleen and thymus, performed under ultrasound or computed tomography guidance, constitutes a minimally invasive, well-tolerated, and cost-effective diagnostic technique. Despite a limited number of published studies on the diagnostic accuracy of FNAB in these organs, it remains a valuable tool particularly when combined with rapid on-site evaluation and ancillary techniques, such as immunophenotypic analysis by flow cytometry or immunocytochemistry and molecular testing. Summary: The WHO System categorizes thymic and splenic cytopathology into five diagnostic categories: “Inadequate/Insufficient/Nondiagnostic,” “Benign,” “Atypical,” “Suspicious for malignancy,” and “Malignant.” This standardized approach aims to enhance diagnostic accuracy, provide risk assessment, and facilitate clinical decision-making. However, applicability of FNAB in the thymus and spleen is still debated, particularly concerning sample adequacy, diagnostic accuracy, and potential complications such as hemorrhage, especially for splenic FNAB. Thymic FNAB is primarily used for diagnosing thymic hyperplasia, thymoma, thymic carcinomas, and lymphomas. However, distinguishing these entities and their subtypes is challenging. Splenic FNAB is valuable in evaluating splenomegaly, infections, lymphomas, and other neoplasms, particularly in staging and monitoring disease progression. While using FNAB to evaluate these organs is not yet a widely adopted standard practice, its role in minimizing unnecessary surgical interventions and guiding therapeutic strategies is being increasingly recognized. Key Messages: The WHO System for the thymus and spleen seeks to establish a harmonized, evidence-based framework for cytopathological diagnosis, incorporating key diagnostic criteria, malignancy risk assessment, and standardized reporting protocols. Future research is needed to refine and develop diagnostic role of FNAB, enhance its integration with advanced molecular techniques, and optimize its use in personalized medicine.
- 14 October 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (2) , 201-210
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 – Spleen and Thymus
Background: The International Academy of Cytology in collaboration with the International Agency for Research on Cancer has developed a standardized World Health Organization Reporting System (WHO System) for the cytopathology of the lymph nodes, spleen, and thymus. Fine-needle aspiration biopsy (FNAB) of the spleen and thymus, performed under ultrasound or computed tomography guidance, constitutes a minimally invasive, well-tolerated, and cost-effective diagnostic technique. Despite a limited number of published studies on the diagnostic accuracy of FNAB in these organs, it remains a valuable tool particularly when combined with rapid on-site evaluation and ancillary techniques, such as immunophenotypic analysis by flow cytometry or immunocytochemistry and molecular testing. Summary: The WHO System categorizes thymic and splenic cytopathology into five diagnostic categories: “Inadequate/Insufficient/Nondiagnostic,” “Benign,” “Atypical,” “Suspicious for malignancy,” and “Malignant.” This standardized approach aims to enhance diagnostic accuracy, provide risk assessment, and facilitate clinical decision-making. However, applicability of FNAB in the thymus and spleen is still debated, particularly concerning sample adequacy, diagnostic accuracy, and potential complications such as hemorrhage, especially for splenic FNAB. Thymic FNAB is primarily used for diagnosing thymic hyperplasia, thymoma, thymic carcinomas, and lymphomas. However, distinguishing these entities and their subtypes is challenging. Splenic FNAB is valuable in evaluating splenomegaly, infections, lymphomas, and other neoplasms, particularly in staging and monitoring disease progression. While using FNAB to evaluate these organs is not yet a widely adopted standard practice, its role in minimizing unnecessary surgical interventions and guiding therapeutic strategies is being increasingly recognized. Key Messages: The WHO System for the thymus and spleen seeks to establish a harmonized, evidence-based framework for cytopathological diagnosis, incorporating key diagnostic criteria, malignancy risk assessment, and standardized reporting protocols. Future research is needed to refine and develop diagnostic role of FNAB, enhance its integration with advanced molecular techniques, and optimize its use in personalized medicine.
- 27 August 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (2) , 185-200
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 1 – Lymph Node
Background: Fine-needle aspiration biopsy (FNAB) of lymph nodes is a widely used method for evaluating lymphadenopathy. FNAB offers general advantages of rapid turnaround time, low cost and minimal morbidity, and more specific advantages in various clinical situations, such as deeply located lymph nodes or patients with significant comorbidities. The FNAB sample can be utilized for a wide range of ancillary tests, including microbiological studies, immunocytochemistry for primary and metastatic neoplasms and flow cytometry immunophenotyping in cases of lymphoid-rich samples, where there is a suspicion for lymphomas. Summary: The increasing application of FNAB in lymph node pathology has led to the development of a standardized reporting system, formalized in the World Health Organization (WHO) Reporting System for Lymph Node, Spleen and Thymus Cytopathology (WHO System). This system is equally applicable to lymph node, spleen and thymus; however, this article focuses on lymph nodes. The WHO System was established through a joint project of the WHO, the International Agency for Research on Cancer (IARC) and the International Academy of Cytology (IAC) and is structured into five diagnostic categories: inadequate/insufficient/non-diagnostic, benign, atypical, suspicious for malignancy, and malignant. The WHO System provides a standardized and reliable means of categorizing various lymph node lesions based on cytopathology findings and enables pathologists to make more accurate and reproducible diagnoses, thereby improving clinical management and treatment decisions. Integrating cellular morphology and clinical-imaging data help distinguish benign from malignant lesions, significantly reducing diagnostic variability. The primary goal was to reduce diagnostic uncertainty and improve patient outcomes through greater consistency and clarity in lymph node cytopathology reports. The WHO System emphasizes the use of rapid on-site assessment (ROSE) to improve diagnostic accuracy and reduce the need for additional diagnostic procedures. The risk of malignancy (ROM) varies by diagnostic category, with higher risks of malignancy in the “Suspicious for malignancy” and “Malignant” categories. The system also includes recommendations for ancillary tests and performance of additional biopsies when further clarification is needed. The WHO System represents a significant advancement in the standardization of lymph node, spleen, and thymus cytopathology, facilitating interdisciplinary communication and improving risk stratification. However, diagnostic challenges remain, particularly in managing inadequate samples and interpreting atypical lesions, necessitating a multidisciplinary approach that integrates clinical, imaging, ancillary testing and, in some cases, core needle, or excision biopsy material. Key messages: The WHO System serves as a crucial tool for refining the diagnosis of the broad range of inflammatory, infectious, metastatic, and lymphomatous processes in lymph node pathologies. In addition, it is suitable for high income as well as most obviously low- and middle-income countries leading to optimizing therapeutic decision-making.
- 27 August 2025
- Published by S. Karger AG in Acta Cytologica
- Vol. 70 (2) , 185-200
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 1 – Lymph Node
Background: Fine-needle aspiration biopsy (FNAB) of lymph nodes is a widely used method for evaluating lymphadenopathy. FNAB offers general advantages of rapid turnaround time, low cost and minimal morbidity, and more specific advantages in various clinical situations, such as deeply located lymph nodes or patients with significant comorbidities. The FNAB sample can be utilized for a wide range of ancillary tests, including microbiological studies, immunocytochemistry for primary and metastatic neoplasms and flow cytometry immunophenotyping in cases of lymphoid-rich samples, where there is a suspicion for lymphomas. Summary: The increasing application of FNAB in lymph node pathology has led to the development of a standardized reporting system, formalized in the World Health Organization (WHO) Reporting System for Lymph Node, Spleen and Thymus Cytopathology (WHO System). This system is equally applicable to lymph node, spleen and thymus; however, this article focuses on lymph nodes. The WHO System was established through a joint project of the WHO, the International Agency for Research on Cancer (IARC) and the International Academy of Cytology (IAC) and is structured into five diagnostic categories: inadequate/insufficient/non-diagnostic, benign, atypical, suspicious for malignancy, and malignant. The WHO System provides a standardized and reliable means of categorizing various lymph node lesions based on cytopathology findings and enables pathologists to make more accurate and reproducible diagnoses, thereby improving clinical management and treatment decisions. Integrating cellular morphology and clinical-imaging data help distinguish benign from malignant lesions, significantly reducing diagnostic variability. The primary goal was to reduce diagnostic uncertainty and improve patient outcomes through greater consistency and clarity in lymph node cytopathology reports. The WHO System emphasizes the use of rapid on-site assessment (ROSE) to improve diagnostic accuracy and reduce the need for additional diagnostic procedures. The risk of malignancy (ROM) varies by diagnostic category, with higher risks of malignancy in the “Suspicious for malignancy” and “Malignant” categories. The system also includes recommendations for ancillary tests and performance of additional biopsies when further clarification is needed. The WHO System represents a significant advancement in the standardization of lymph node, spleen, and thymus cytopathology, facilitating interdisciplinary communication and improving risk stratification. However, diagnostic challenges remain, particularly in managing inadequate samples and interpreting atypical lesions, necessitating a multidisciplinary approach that integrates clinical, imaging, ancillary testing and, in some cases, core needle, or excision biopsy material. Key messages: The WHO System serves as a crucial tool for refining the diagnosis of the broad range of inflammatory, infectious, metastatic, and lymphomatous processes in lymph node pathologies. In addition, it is suitable for high income as well as most obviously low- and middle-income countries leading to optimizing therapeutic decision-making.
- Open Access
- 25 May 2024
- Published by Scientific Scholar in Cytojournal
- Vol. 21, 18
Squash surprise in an elderly female
- 25 May 2024
- Published by Scientific Scholar in Cytojournal
- Vol. 21, 18
Open AccessSquash surprise in an elderly female
- 19 May 2022
- Published by Springer Nature in European Radiology
- Vol. 32 (10) , 6668-6677
Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study
Objective To evaluate the role of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of solid pancreatic head lesions (SPHL). Methods This prospective study comprised consecutive patients with SPHL who underwent CEUS evaluation of the pancreas. Findings recorded at CEUS were enhancement patterns (degree, completeness, centripetal enhancement, and percentage enhancement) and presence of central vessels. In addition, time to peak (TTP) and washout time (WT) were recorded. The final diagnosis was based on histopathology or cytology. Multivariate analysis was performed to identify parameters that were significantly associated with pancreatic ductal adenocarcinoma (PDAC). Results Ninety-eight patients (median age 53.8 years, 59 males) were evaluated. The final diagnosis was PDAC (n = 64, 65.3%), inflammatory mass (n = 16, 16.3%), neuroendocrine tumor (NET, n = 14, 14.3%), and other tumors (n = 4, 4.1%). Hypoenhancement, incomplete enhancement, and centripetal enhancement were significantly more common in PDAC than non-PDAC lesions (p = 0.001, p = 0.031, and p = 0.002, respectively). Central vessels were present in a significantly greater number of non-PDAC lesions (p = 0.0001). Hypoenhancement with < 30% enhancement at CEUS had sensitivity and specificity of 80.6% and 67.7%, respectively, for PDAC. There was no significant difference in the TTP and WT between PDAC and non - PDAC lesions. However, the WT was significantly shorter in PDAC compared to NET (p = 0.011). In multivariate analysis, lack of central vessels was significantly associated with a PDAC diagnosis. Conclusion CEUS is a useful tool for the evaluation of SPHL. CEUS can be incorporated into the diagnostic algorithm to differentiate PDAC from non-PDAC lesions. Key Points • Hypoenhancement and incomplete enhancement at CEUS were significantly more common in PDAC than in non-PDAC. • Central vessels at CEUS were significantly associated with PDAC. • There was no difference in TTP and WT between PDAC and non-PDAC lesions.
- 19 May 2022
- Published by Springer Nature in European Radiology
- Vol. 32 (10) , 6668-6677
Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study
Objective To evaluate the role of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of solid pancreatic head lesions (SPHL). Methods This prospective study comprised consecutive patients with SPHL who underwent CEUS evaluation of the pancreas. Findings recorded at CEUS were enhancement patterns (degree, completeness, centripetal enhancement, and percentage enhancement) and presence of central vessels. In addition, time to peak (TTP) and washout time (WT) were recorded. The final diagnosis was based on histopathology or cytology. Multivariate analysis was performed to identify parameters that were significantly associated with pancreatic ductal adenocarcinoma (PDAC). Results Ninety-eight patients (median age 53.8 years, 59 males) were evaluated. The final diagnosis was PDAC (n = 64, 65.3%), inflammatory mass (n = 16, 16.3%), neuroendocrine tumor (NET, n = 14, 14.3%), and other tumors (n = 4, 4.1%). Hypoenhancement, incomplete enhancement, and centripetal enhancement were significantly more common in PDAC than non-PDAC lesions (p = 0.001, p = 0.031, and p = 0.002, respectively). Central vessels were present in a significantly greater number of non-PDAC lesions (p = 0.0001). Hypoenhancement with < 30% enhancement at CEUS had sensitivity and specificity of 80.6% and 67.7%, respectively, for PDAC. There was no significant difference in the TTP and WT between PDAC and non - PDAC lesions. However, the WT was significantly shorter in PDAC compared to NET (p = 0.011). In multivariate analysis, lack of central vessels was significantly associated with a PDAC diagnosis. Conclusion CEUS is a useful tool for the evaluation of SPHL. CEUS can be incorporated into the diagnostic algorithm to differentiate PDAC from non-PDAC lesions. Key Points • Hypoenhancement and incomplete enhancement at CEUS were significantly more common in PDAC than in non-PDAC. • Central vessels at CEUS were significantly associated with PDAC. • There was no difference in TTP and WT between PDAC and non-PDAC lesions.
- Open Access
- 6 January 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 1
Cytomorphological spectrum of metastatic bone tumors: Experience at a tertiary care center
Objectives: Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. Fine-needle aspiration cytology (FNAC) provides reasonably accurate pre-operative diagnosis in vast majority of cases. This study aims to elicit the cytomorphological detail of various metastatic bone tumors. Material and Methods: A total of 109 cases of tumors metastatic to bone have been included in this study. The details of the cases were available from the archives of the department of cytology. May Grunwald Giemsa and hematoxylin and eosin stained smears were studied and examined for the cytomorphological spectrum. Cell block and immunohistochemistry tests were done, wherever feasible. Results: Among 109 patients, the mean age was 54.52 years. There was male preponderance with 90 males and 19 females. The most common site of metastases was in the vertebra (82 cases), and 76 cases were in the dorsolumbar region. The most common type of tumor metastasizing was adenocarcinoma. Conclusion: FNAC is a very useful, economical procedure. There are characteristic cytological features of the metastatic lesions and the basic diagnostic categorization of the malignant tumors is possible on FNAC. Regarding the primary source clinical history, radiological features of the primary tumor, if any, and immunocytochemistry may be needed.
- 6 January 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 1
Open AccessCytomorphological spectrum of metastatic bone tumors: Experience at a tertiary care center
Objectives: Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. Fine-needle aspiration cytology (FNAC) provides reasonably accurate pre-operative diagnosis in vast majority of cases. This study aims to elicit the cytomorphological detail of various metastatic bone tumors. Material and Methods: A total of 109 cases of tumors metastatic to bone have been included in this study. The details of the cases were available from the archives of the department of cytology. May Grunwald Giemsa and hematoxylin and eosin stained smears were studied and examined for the cytomorphological spectrum. Cell block and immunohistochemistry tests were done, wherever feasible. Results: Among 109 patients, the mean age was 54.52 years. There was male preponderance with 90 males and 19 females. The most common site of metastases was in the vertebra (82 cases), and 76 cases were in the dorsolumbar region. The most common type of tumor metastasizing was adenocarcinoma. Conclusion: FNAC is a very useful, economical procedure. There are characteristic cytological features of the metastatic lesions and the basic diagnostic categorization of the malignant tumors is possible on FNAC. Regarding the primary source clinical history, radiological features of the primary tumor, if any, and immunocytochemistry may be needed.
- Open Access
- 27 July 2021
- Published by Scientific Scholar in Cytojournal
- Vol. 18, 17
Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid
Objectives: Peritoneal fluid cytology is done routinely in cases with serous carcinoma of ovary. However, morphologic features of borderline serous tumors (BSTs) of ovary in ascitic fluid have been rarely described. The aim of our study was to evaluate the morphologic features of BST with and without ascitic fluid involvement (BST+ and BST-, respectively) and compare with those of serous carcinomas, both in conventional and liquid-based cytology (LBC) smears. Material and Methods: Out of 30 BST cases reported in 3 years, seven cases had BST+. We compared the cytomorphology of seven cases of BST+, seven cases of BST-, and seven cases of serous adenocarcinoma with positive ascitic fluid cytology. Both conventional and LBC smears were studied in all cases and compared. Histopathology of omentum in these cases was also studied. Results: Most cases with BST+ had regular papillary fragment borders with nuclei showing mild-to-moderate pleomorphism, fine nuclear chromatin with small nucleoli as compared with serous carcinomas all of which had irregular borders with moderate-to-severe nuclear pleomorphism, coarse chromatin, and macronucleoli. Conclusion: A combination of cytoarchitectural and nuclear features can help in suspecting BST in ascitic fluid. Ascitic fluid cytology together with tissue histology can increase the rate of the detection of peritoneal implants.
- 27 July 2021
- Published by Scientific Scholar in Cytojournal
- Vol. 18, 17
Open AccessCytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid
Objectives: Peritoneal fluid cytology is done routinely in cases with serous carcinoma of ovary. However, morphologic features of borderline serous tumors (BSTs) of ovary in ascitic fluid have been rarely described. The aim of our study was to evaluate the morphologic features of BST with and without ascitic fluid involvement (BST+ and BST-, respectively) and compare with those of serous carcinomas, both in conventional and liquid-based cytology (LBC) smears. Material and Methods: Out of 30 BST cases reported in 3 years, seven cases had BST+. We compared the cytomorphology of seven cases of BST+, seven cases of BST-, and seven cases of serous adenocarcinoma with positive ascitic fluid cytology. Both conventional and LBC smears were studied in all cases and compared. Histopathology of omentum in these cases was also studied. Results: Most cases with BST+ had regular papillary fragment borders with nuclei showing mild-to-moderate pleomorphism, fine nuclear chromatin with small nucleoli as compared with serous carcinomas all of which had irregular borders with moderate-to-severe nuclear pleomorphism, coarse chromatin, and macronucleoli. Conclusion: A combination of cytoarchitectural and nuclear features can help in suspecting BST in ascitic fluid. Ascitic fluid cytology together with tissue histology can increase the rate of the detection of peritoneal implants.
- Open Access
- 1 July 2021
- Published by Medknow in Journal of Cytology
- Vol. 38 (3) , 164-170
Fine-Needle Aspiration Diagnosis of Lymphoma Based on Cytomorphology Alone
Context: Fine-needle aspiration cytology (FNAC) is a rapid and accurate first-line diagnostic modality in lymphadenopathy. Aims: To determine the utility of FNAC for the diagnosis of lymphoma and highlight the various pitfalls in morphological interpretation. Settings and Design: This was a retrospective study of 3 years duration in which cytology diagnosis was compared with the follow-up histopathology diagnosis wherever available. Results: A cytodiagnosis of lymphoma was made in a total of 868 cases (2.8%) out of nearly 33,000 FNAC performed during the study period; 556 (64.1%) cases were diagnosed as non-Hodgkin lymphoma (NHL), 198 (22.8%) as Hodgkin lymphoma (HL), and in 114 (13.1%) cases, a cytological diagnosis of lymphoma without further categorization was given. Histopathological reports were available in 348 cases, with an overall concordance rate of 93.1% (324), which was slightly higher in the HL cases (95.8%) as compared to NHL (91.7%). Twenty-four cases (6.9%) showed discordant cytological diagnosis with subsequent histopathology. The main reasons for the erroneous diagnosis were the over-interpretation of the germinal center cells as atypical lymphoid cells, over-interpretation of immunoblasts with prominent nucleoli as Hodgkin cells, and sheets of monomorphic lymphoid cells interpreted as low-grade lymphoma. Conclusion: Cytomorphology alone can make a correct basic diagnosis of lymphoma with a high degree of accuracy. The errors in interpretation can be further reduced by careful attention to the diagnostic pitfalls and common differential diagnoses.
- 1 July 2021
- Published by Medknow in Journal of Cytology
- Vol. 38 (3) , 164-170
Open AccessFine-Needle Aspiration Diagnosis of Lymphoma Based on Cytomorphology Alone
Context: Fine-needle aspiration cytology (FNAC) is a rapid and accurate first-line diagnostic modality in lymphadenopathy. Aims: To determine the utility of FNAC for the diagnosis of lymphoma and highlight the various pitfalls in morphological interpretation. Settings and Design: This was a retrospective study of 3 years duration in which cytology diagnosis was compared with the follow-up histopathology diagnosis wherever available. Results: A cytodiagnosis of lymphoma was made in a total of 868 cases (2.8%) out of nearly 33,000 FNAC performed during the study period; 556 (64.1%) cases were diagnosed as non-Hodgkin lymphoma (NHL), 198 (22.8%) as Hodgkin lymphoma (HL), and in 114 (13.1%) cases, a cytological diagnosis of lymphoma without further categorization was given. Histopathological reports were available in 348 cases, with an overall concordance rate of 93.1% (324), which was slightly higher in the HL cases (95.8%) as compared to NHL (91.7%). Twenty-four cases (6.9%) showed discordant cytological diagnosis with subsequent histopathology. The main reasons for the erroneous diagnosis were the over-interpretation of the germinal center cells as atypical lymphoid cells, over-interpretation of immunoblasts with prominent nucleoli as Hodgkin cells, and sheets of monomorphic lymphoid cells interpreted as low-grade lymphoma. Conclusion: Cytomorphology alone can make a correct basic diagnosis of lymphoma with a high degree of accuracy. The errors in interpretation can be further reduced by careful attention to the diagnostic pitfalls and common differential diagnoses.
- 21 March 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e28996
Diagnostic accuracy and cytomorphological spectrum of Wilms tumour in fine needle aspiration biopsy cytology samples supplemented with cell blocks
Objective: Paediatric malignant renal neoplasms are subjected to neoadjuvant chemotherapy as per Societe Internationale d'Oncologie Pediatrique; International Society of Pediatric Oncology (SIOP) protocol. An accurate tissue diagnosis is required prior to institution of chemotherapy, and hence the aim of this study was to evaluate the diagnostic accuracy of fine needle aspiration biopsy cytology (FNABC) along with cell block histology.Materials and Methods: A retrospective audit of all paediatric renal neoplasms diagnosed by FNABC between 2015 and 2019 was performed. Histopathology correlation was done wherever available. WT cases were subjected to detailed cytomorphological evaluation.Results: A total of 121 cases of paediatric renal neoplasms including 109 WT, four clear cell sarcoma, one malignant rhabdoid tumour and three mesoblastic nephroma were evaluated. The age range was 4 weeks to 8 years. FNABC samples were adequate for diagnosis in 120 of 121 cases (99.18%) and a definitive cytological diagnosis was achieved in 117 cases (96.7%). The specificity and sensitivity for a cytopathological diagnosis of WT were 98.7% and 97.4%, respectively. On detailed cytomorphological analysis of 68 histopathology‐proven WT, 40 (58.8%) cases were triphasic, 23 (35.3%) were biphasic and four were composed of blastema only. The corresponding cell blocks provided additional information over the conventional smears in 23 (33.8%) cases, with epithelial or mesenchymal elements recognised and evidence of rhabdomyoblastic differentiation.Conclusion: FNABC along with cell block histology is highly accurate for diagnosis of WT and other malignant paediatric renal neoplasms and is recommended as the technique of choice in centres with cytopathology expertise for establishing a cellular diagnosis prior to commencement of neoadjuvant chemotherapy.
- 21 March 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e28996
Diagnostic accuracy and cytomorphological spectrum of Wilms tumour in fine needle aspiration biopsy cytology samples supplemented with cell blocks
Objective: Paediatric malignant renal neoplasms are subjected to neoadjuvant chemotherapy as per Societe Internationale d'Oncologie Pediatrique; International Society of Pediatric Oncology (SIOP) protocol. An accurate tissue diagnosis is required prior to institution of chemotherapy, and hence the aim of this study was to evaluate the diagnostic accuracy of fine needle aspiration biopsy cytology (FNABC) along with cell block histology.Materials and Methods: A retrospective audit of all paediatric renal neoplasms diagnosed by FNABC between 2015 and 2019 was performed. Histopathology correlation was done wherever available. WT cases were subjected to detailed cytomorphological evaluation.Results: A total of 121 cases of paediatric renal neoplasms including 109 WT, four clear cell sarcoma, one malignant rhabdoid tumour and three mesoblastic nephroma were evaluated. The age range was 4 weeks to 8 years. FNABC samples were adequate for diagnosis in 120 of 121 cases (99.18%) and a definitive cytological diagnosis was achieved in 117 cases (96.7%). The specificity and sensitivity for a cytopathological diagnosis of WT were 98.7% and 97.4%, respectively. On detailed cytomorphological analysis of 68 histopathology‐proven WT, 40 (58.8%) cases were triphasic, 23 (35.3%) were biphasic and four were composed of blastema only. The corresponding cell blocks provided additional information over the conventional smears in 23 (33.8%) cases, with epithelial or mesenchymal elements recognised and evidence of rhabdomyoblastic differentiation.Conclusion: FNABC along with cell block histology is highly accurate for diagnosis of WT and other malignant paediatric renal neoplasms and is recommended as the technique of choice in centres with cytopathology expertise for establishing a cellular diagnosis prior to commencement of neoadjuvant chemotherapy.
- 16 October 2020
- Published by Wiley in Cytopathology
- Vol. 32 (3) , 374-377
Bilateral renal masses in an adult with haematuria
Renal angiomyolipoma (AML) is a rare, benign mesenchymal neoplasm belonging to the broad family of perivascular epithelioid cell tumors. It can occur sporadically or in association with tuberous sclerosis complex. In the absence of typical radiologic features, a definitive diagnosis of AML requires microscopic examination of the tumor tissue. Herein, we present a case of an adult male presenting with hematuria and flank pain, diagnosed as having bilateral renal angiomyolipoma on fine needle aspiration cytology supplemented by cell‐block immunocytochemistry.
- 16 October 2020
- Published by Wiley in Cytopathology
- Vol. 32 (3) , 374-377
Bilateral renal masses in an adult with haematuria
Renal angiomyolipoma (AML) is a rare, benign mesenchymal neoplasm belonging to the broad family of perivascular epithelioid cell tumors. It can occur sporadically or in association with tuberous sclerosis complex. In the absence of typical radiologic features, a definitive diagnosis of AML requires microscopic examination of the tumor tissue. Herein, we present a case of an adult male presenting with hematuria and flank pain, diagnosed as having bilateral renal angiomyolipoma on fine needle aspiration cytology supplemented by cell‐block immunocytochemistry.